CompletedNCT02025543

Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content

Studying Hereditary Hemochromatosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Wisconsin, Madison
Principal Investigator: Scott Reeder, MD PhD
University of Wisconsin, Madison
Intervention: MRI(device)
Enrollment: 207 enrolled
Eligibility: 8-89 years · All sexes
Timeline: 2015 – 2019

Study locations (4)

Stanford University, Palo Alto, California, United States
Johns Hopkins University, Baltimore, Maryland, United States
University of Texas-Southwestern, Dallas, Texas, United States
University of Wisconsin, Madison, Madison, Wisconsin, United States

Collaborators

Johns Hopkins University · Stanford University · University of Texas · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02025543 on ClinicalTrials.gov

← Back to all trials